GSE157899
Integrative transcriptomic and proteomic analyses reveal that 15,16-dihydrotanshinone I inhibits  infantile hemangioma by interfering in posttranscriptional processing of hypoxia-inducible factor 1
Our team found that 15,16-dihydrotanshinone I (DHTS) was significantly effective at inhibiting infantile hemangioma proliferation in vitro and in vivo. To investigate the underlying mechanism by which DHTS inhibits hemangioma, we compared the transcriptomes of control and DHTS-treated hemangioma cells. Overall design: mRNA profiles of control EOMA cells(treated by DMSO) and DHTS-treated EOMA cells